Merck & Co, Inc. (MRK) CEO Ken Frazier on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/29/21
Oncologic Drugs Adcomm Backs Merck's Keytruda, Roche's Tecentriq Accelerated Approvals In Bladder CancerBenzinga • 04/29/21
Merck Stock Dives As Pandemic Bungles First-Quarter Sales, EarningsInvestors Business Daily • 04/29/21
Merck Earnings Fall Short of Expectations As Sales Weakened By Widespread InfectionsBenzinga • 04/29/21
Merck stock drops after adjusted profit surprisingly falls, revenue comes up shortMarket Watch • 04/29/21
Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, ProductionBenzinga • 04/27/21
Merck in licensing deals with 5 Indian generic drug makers to expand access to COVID-19 therapryMarket Watch • 04/27/21
Amid Humanitarian Crisis in India, Merck Announces Voluntary Licensing Agreements with Five Indian Generics Manufacturers to Accelerate and Expand Global Access to Molnupiravir, an Investigational Oral Therapeutic for the Treatment of COVID-19Business Wire • 04/27/21
This Pharma Giant Lost the Vaccine Race, But Its COVID-19 Journey May Not Be OverThe Motley Fool • 04/27/21